• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Vincent T. Ho, MD

Associate Professor, Department of Medicine, Harvard Medical School

Instructor in Medicine, Adult Oncology, Dana-Farber Cancer Institute

Contact Info

Vincent Ho
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA, 02215
Mailstop: D1B21
Phone not available.
vtho@partners.org

Assistant

Not Available.

DF/HCC Program Affiliation

Lymphoma and Myeloma
Leukemia

Research Abstract

My academic focus is clinical research in the field of allogeneic hematopoietic stem cell transplantation. My specific interests revolve around post transplant toxicity, T-cell depletion, and adoptive immunotherapy. I am the co-principal investigator of an on-going clinical trial testing the infusion of donor derived dendritic cells (DC) along with DLI in patients with disease relapse after HSCT. The goal of this study is to assess the safety of DC infusion, and may lead to future studies using donor DCs to augment GVL activity post transplant.I am also the author and principal investigator of a clinical trial investigating the feasibility and safety of administering a GM-SCF secreting leukemia cell vaccine (G-VAX) to patients with active MDS/myeloid leukemia following a non-myeloablative stem cell transplant. This is an important pilot study investigating the potential use of tumor vaccine post allogeneic transplant to stimulate GVL activity.

Publications

View All Publications